Related Experiment Video
Updated: Apr 25, 2026

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
9.0K
Epidemiology of MPN: what do we know?
1Centre for Public Health, Queen's University Belfast, Grosvenor Road, Belfast, BT12 6BJ, Northern Ireland, l.anderson@qub.ac.uk.
Current Hematologic Malignancy Reports
|August 18, 2014
Summary
Myeloproliferative neoplasms (MPNs) involve myeloid cell overproduction. While incidence, prevalence, and survival are reviewed, the exact causes of these blood cancers remain unknown, necessitating further research.
Area of Science:
- Hematology
- Oncology
Background:
- Myeloproliferative neoplasms (MPNs) are a group of blood cancers characterized by the overproduction of myeloid cells.
- This group includes chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, myelofibrosis, and rare disorders like chronic neutrophilic leukemia, chronic eosinophilic leukemia, and mastocytosis.
Purpose of the Study:
- To review current worldwide incidence and prevalence rates of MPNs.
- To describe survival data for each MPN condition.
- To discuss potential etiological factors based on recent studies.
Main Methods:
- Literature review of worldwide incidence and prevalence data.
- Compilation and description of survival statistics for various MPNs.
- Analysis of recent studies on risk factors including lifestyle, medical history, and environmental exposures.
Main Results:
- Presents reported incidence and prevalence rates from global literature.
- Summarizes survival outcomes for different myeloproliferative neoplasms.
- Discusses various potential contributing factors to MPN development, such as BMI, diet, smoking, alcohol, allergies, comorbidities, occupation, and environmental exposures.
Conclusions:
- The precise etiology of myeloproliferative neoplasms remains largely unknown.
- Current knowledge highlights significant gaps and underscores the critical need for more comprehensive research into the causes of MPNs.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Disorders of Leukocytes
2.3K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K

